Abstract 7005: Tumor cell CEBPB expression contributes to T cell-mediated immune evasion of microsatellite stable colorectal cancer

Abstract Background: Microsatellite stable (MSS) colorectal cancer (CRC), which accounts for approximately 80-85% of all colorectal cancer cases, exhibits a poor response to immune checkpoint inhibitors. Tumor protein 53 (TP53) mutations are frequently observed in colorectal cancer and may contribute to tumor-driven immunosuppression. In this study, we aimed to investigate the immunosuppressive mechanisms associated with TP53 mutations in MSS CRC. Methods: We performed single-cell RNA sequencing (scRNA-seq) on tumor samples from 30 CRC patients and Trp53- knockout (KO) CT26 tumors in syngeneic mice to profile the tumor microenvironment and analyze tumor cell gene expression profiles based on TP53 mutation status. We identified CCAAT enhancer-binding protein beta (CEBPB) as a potential immunosuppressive factor associated with TP53-mutant CRC. To demonstrate the role of CEBPB in T cell immunosuppression, we analyzed T cell-tumor cell co-cultures and CEBPB-overexpressing (oe) tumor-injected syngeneic mouse models by flow cytometry. Results: scRNA-seq analysis of 30 CRCs revealed increased proportions of CD4+ T cell subsets, including Treg, Th17, and Tcm cells, in TP53 mutant tumors. Immune activation pathways, such as the immune system and interferon-gamma response, were down-regulated in T cells compared to TP53 wild-type tumors, suggesting that TP53 mutations might contribute to immune evasion by negatively affecting T cells. scRNA-seq analysis of Trp53-KO CT26 tumors identified CEBPB as notably upregulated, and we confirmed that loss of Trp53 WT led to increased CEBPB mRNA expression and protein stability in CRC cell lines. CEBPB expression was associated with reduced CD4+ T cell infiltration and positively correlated with cytotoxic T lymphocyte-associated protein 4 (CTLA4) expression in regulatory T cells (Treg) and exhausted T cells (Tex). CEBPB-oe CT26 tumors in syngeneic mice showed reduced CD4+ T cell infiltration and upregulation of CTLA-4 expression on CD4+ T cells in vivo. Consistently, spleen T co-cultured with CEBPB-overexpressing CT26 cells showed increased CTLA-4 expression and decreased proliferation of CD4+ T cells. Conclusion: Tumor cell CEBPB expression, upregulated by TP53 mutation, may mediate T cell-mediated immunosuppression and is considered as potential therapeutic target for regulating immune evasion in MSS CRC. Citation Format: Hye Jeong Yun, Chan Ho Park, Dahye Yun, Hye-Ri Shin, Naeun Park, Changhee Park, Jeong Dong Lee, Kiyeon Kim, Heejun Shim, Hyejin Sim, Se Min Kim, Min Jung Kim, Ji Won Park, Seung-Bum Ryoo, Yoojoo Lim, Seung-Yong Jeong, Kyu Joo Park, Tae-You Kim, Junil Kim, Jae-Kyung Won, Sae-Won Han. Tumor cell CEBPB expression contributes to T cell-mediated immune evasion of microsatellite stable colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7005.